Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Eukaryotic DNA topoisomerases I.

× No keyword cloud information.

53 in total

1. A model for the mechanism of strand passage by DNA gyrase.

Authors: S C Kampranis; A D Bates; A Maxwell
Journal: Proc Natl Acad Sci U S A Date: 1999-07-20 Impact factor: 11.205

2. Conversion of topoisomerase I cleavage complexes on the leading strand of ribosomal DNA into 5'-phosphorylated DNA double-strand breaks by replication runoff.

Authors: D Strumberg; A A Pilon; M Smith; R Hickey; L Malkas; Y Pommier
Journal: Mol Cell Biol Date: 2000-06 Impact factor: 4.272

3. Gadd45, a p53-responsive stress protein, modifies DNA accessibility on damaged chromatin.

Authors: F Carrier; P T Georgel; P Pourquier; M Blake; H U Kontny; M J Antinore; M Gariboldi; T G Myers; J N Weinstein; Y Pommier; A J Fornace
Journal: Mol Cell Biol Date: 1999-03 Impact factor: 4.272

4. Mechanism of DNA transesterification by vaccinia topoisomerase: catalytic contributions of essential residues Arg-130, Gly-132, Tyr-136 and Lys-167.

Authors: J Wittschieben; S Shuman
Journal: Nucleic Acids Res Date: 1997-08-01 Impact factor: 16.971

5. Mutational analysis of vaccinia virus topoisomerase identifies residues involved in DNA binding.

Authors: J Sekiguchi; S Shuman
Journal: Nucleic Acids Res Date: 1997-09-15 Impact factor: 16.971

6. Residues 190-210 of human topoisomerase I are required for enzyme activity in vivo but not in vitro.

Authors: Morten O Christensen; Hans U Barthelmes; Fritz Boege; Christian Mielke
Journal: Nucleic Acids Res Date: 2003-12-15 Impact factor: 16.971

7. In vivo sequencing of camptothecin-induced topoisomerase I cleavage sites in human colon carcinoma cells.

Authors: C Pondarré; D Strumberg; A Fujimori; R Torres-León; Y Pommier
Journal: Nucleic Acids Res Date: 1997-10-15 Impact factor: 16.971

8. A novel DNA topoisomerase I inhibitor with different mechanism from camptothecin induces G2/M phase cell cycle arrest to K562 cells.

Authors: Ning Wu; Xi-Wei Wu; Keli Agama; Yves Pommier; Jun Du; Ding Li; Lian-Quan Gu; Zhi-Shu Huang; Lin-Kun An
Journal: Biochemistry Date: 2010-11-08 Impact factor: 3.162

9. Synthesis and biological evaluation of the first dual tyrosyl-DNA phosphodiesterase I (Tdp1)-topoisomerase I (Top1) inhibitors.

Authors: Trung Xuan Nguyen; Andrew Morrell; Martin Conda-Sheridan; Christophe Marchand; Keli Agama; Alun Bermingham; Alun Bermingam; Andrew G Stephen; Adel Chergui; Alena Naumova; Robert Fisher; Barry R O'Keefe; Yves Pommier; Mark Cushman
Journal: J Med Chem Date: 2012-04-26 Impact factor: 7.446

10. Synergistic interactions between aminoflavone, paclitaxel and camptothecin in human breast cancer cells.

Authors: Kathryn E Reinicke; Mary J Kuffel; Matthew P Goetz; Matthew M Ames
Journal: Cancer Chemother Pharmacol Date: 2009-12-11 Impact factor: 3.333